Skip to main content Skip to section navigation Skip to footer
  • About
    • Discover Mineralys
    • Purpose & Values
    • Our Team
  • Science
    • Lorundrostat
    • Aldosterone
    • Hypertension
    • Cardio-Renal-Metabolic Syndrome
  • Pipeline
  • Investors
  • Publications
  • Contact Us
    • Careers & Culture
    • Partnering
    • Contact Form
Menu
  • About
    • Discover Mineralys
    • Purpose & Values
    • Our Team
  • Science
    • Lorundrostat
    • Aldosterone
    • Hypertension
    • Cardio-Renal-Metabolic Syndrome
  • Pipeline
  • Investors
  • Publications
  • Contact Us
    • Careers & Culture
    • Partnering
    • Contact Form

IR Calendar

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • SEC Filings
    • All SEC Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix

  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts

Fourth Quarter and Full Year 2023 Earnings Call

Mar 21, 2024 8:30 am EST
Earnings Release
HTML PDF
10-K Filing
HTML PDF
XBRL
ZIP
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2024 Mineralys Therapeutics, LLC
  • Terms & Conditions
  • Privacy Policy
  • X/Twitter Icon Twitter
  • Linkedin